A mega-analysis of genome-wide association studies for major depressive disorder

Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Lisa Jones

    Research output: Contribution to journalArticlepeer-review

    717 Citations (Scopus)

    Abstract

    Prior genome-wide association studies (GWAS) of major depressive disorder (MDD) have met with limited success. We sought to increase statistical power to detect disease loci by conducting a GWAS mega-analysis for MDD. In the MDD discovery phase, we analyzed more than 1.2 million autosomal and X chromosome single-nucleotide polymorphisms (SNPs) in 18 759 independent and unrelated subjects of recent European ancestry (9240 MDD cases and 9519 controls). In the MDD replication phase, we evaluated 554 SNPs in independent samples (6783 MDD cases and 50 695 controls). We also conducted a cross-disorder meta-analysis using 819 autosomal SNPs with P
    Original languageEnglish
    JournalMolecular Psychiatry
    DOIs
    Publication statusPublished - 2012

    Fingerprint

    Dive into the research topics of 'A mega-analysis of genome-wide association studies for major depressive disorder'. Together they form a unique fingerprint.

    Cite this